Researchers at Tufts University Discuss Findings in Drug Development (The Use of Real-World Evidence and Data in Clinical Research and Postapproval…
Researchers at Tufts University Discuss Findings in Drug Development (The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies)
By a
Our news editors obtained a quote from the research from
According to the news editors, the research concluded: "Expanding the use of RWE in regulatory decision making and increasing uses of real-world data by sponsors will fill the gaps that are critically needed for drug development and safety."
For more information on this research see: The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies. Therapeutic Innovation & Regulatory Science, 2018;():2168479018764662 (see also Drugs and Therapies - Drug Development).
The news editors report that additional information may be obtained by contacting
The direct object identifier (DOI) for that additional information is: https://doi.org/10.1177/2168479018764662. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
Medicare Program; Durable Medical Equipment Fee Schedule Adjustments To Resume the Transitional 50/50 Blended Rates To Provide Relief in Rural Areas and Non-Contiguous Areas
Recent Research from University of Southampton Highlight Findings in Health Insurance (Determinants of National Health Insurance enrolment in Ghana…
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News